کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3001013 | 1180358 | 2006 | 8 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Management of Hodgkin Lymphoma
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
FDG-PETEORTCCoPPASCTABVDBEACOPPHDCTMOPPcomputed tomography - توموگرافی کامپیوتری یا سی تی اسکن یا مقطعنگاری رایانهایEuropean Organization for the Research and Treatment of Cancer - سازمان اروپایی برای تحقیق و درمان سرطانHigh-dose chemotherapy - شیمی درمانی با دوزهای بالاHodgkin lymphoma - لنفوم هاجکینHIV - ویروس نقص ایمنی انسانی human immunodeficiency virus - ویروس نقص ایمنی انسانیAutologous stem cell transplantation - پیوند سلول های بنیادی اتولوگ
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
کاردیولوژی و پزشکی قلب و عروق
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Management of Hodgkin Lymphoma Management of Hodgkin Lymphoma](/preview/png/3001013.png)
چکیده انگلیسی
Approximately 7350 new cases of Hodgkin lymphoma (HL) are diagnosed annually in the United States. The incidence of HL has a bimodal pattern, with the highest incidence seen in young adults and in elderly patients. The disease is composed of 2 distinct entities: the more commonly diagnosed classical HL and the rare nodular lymphocyte-predominant HL. Classical HL includes the subgroups nodular sclerosis, mixed cellularity, lymphocyte depletion, and lymphocyte rich. Selection of the appropriate therapy is based on accurately assessing the stage of disease. Patients with early-stage disease are treated with combined modality strategies using abbreviated courses of combination chemotherapy followed by involved-field radiation therapy, whereas those with advanced-stage disease receive a longer course of chemotherapy without radiation therapy. Currently, more than 80% of all patients with newly diagnosed HL are expected to be long-term survivors. Although many patients respond well to initial therapies and have durable long-term remissions, a subset of patients has resistant disease and experiences relapse even after subsequent high-dose chemotherapy and autologous stem cell transplantation. New therapies are clearly needed for these patients.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Mayo Clinic Proceedings - Volume 81, Issue 3, March 2006, Pages 419-426
Journal: Mayo Clinic Proceedings - Volume 81, Issue 3, March 2006, Pages 419-426
نویسندگان
Stephen M. MD, PhD, James O. MD,